Abstract: A display may include organic light-emitting diode (OLED) pixels. Each pixel may include OLED layers that are interposed between an anode and a cathode. The anode may be formed on a substrate. A layer of material that defines a plurality of bumps or recesses may be formed on the substrate. The anode may conform to the layer of material and may have a plurality of curved portions that are aligned with the bumps or recesses. The anode may have a side mirror portion that conforms to a tapered surface. A black pixel definition layer may be positioned above or below the side mirror portion of the anode. A pixel may include a pixel definition layer that defines multiple light-emitting apertures that overlap a single anode. The multiple light-emitting apertures may have circular, square, or non-square rectangular footprints.

Abstract: An organic photovoltaic device comprises an anode and a cathode, an active layer positioned between the anode and the cathode, comprising a first donor material and a first acceptor material in a first ratio, and an interface layer positioned between the anode and the cathode, comprising a second donor material and a second acceptor material in a second ratio. A method of fabricating an organic photovoltaic device and an organic photovoltaic device produced with the disclosed methods are also disclosed herein.

Abstract: A composition and a method are provided for improving number and/or function of muscle satellite cells, and/or treating or preventing muscle atrophy in a subject in need thereof. Such a composition comprising a homogenous polysaccharide or a derivative thereof, or a pharmaceutically acceptable ester or salt thereof, or a pharmaceutically acceptable solvate thereof, or any combination thereof, and a pharmaceutically acceptable excipient. The homogeneous polysaccharide consists essentially of arabinose, galactose, rhamnose, and galacturonic acid as monomer units. Such a method comprises administrating an effective amount of such a composition into a subject in need thereof.

Abstract: An organic photovoltaic device comprises an anode and a cathode, an active layer positioned between the anode and the cathode, comprising a first donor material and a first acceptor material in a first ratio, and an interface layer positioned between the anode and the cathode, comprising a second donor material and a second acceptor material in a second ratio. A method of fabricating an organic photovoltaic device and an organic photovoltaic device produced with the disclosed methods are also disclosed herein.

Abstract: A method for preparing a model of an animal suffering from non-human mammal obesity or a related disease, comprising the following steps: (a) providing a cell of a non-human mammal, and inactivating Glce gene in the cell, thereby obtaining a non-human mammal cell with an inactivated Glce gene; and (b) using the cell having an inactivated Glce gene obtained in step (a) to prepare and obtain a model of an animal suffering from Glce gene-inactivated obesity or a related disease. The animal model is an effective model for an animal suffering from obesity or a related disease, which may be used for researching diseases such as obesity, hyperlipidemia, hypertension, and diabetes, and may also be used for screening and testing experiments of specific drugs.

Abstract: The present invention discloses a sulfated derivative of polysaccharide extracted from gastrodia elata BL., the preparation method thereof and the use thereof in preparing antineoplastic medicaments, wherein, the gastrodia elata polysaccharide has the following structure: wherein, x and y are each an integer, and x+y=16, “n” is and integer, and the mean molecular weight of the polysaccharide from gastrodia elata is estimated as 2.8×105, the specific rotation of the polysaccharide is +95° in a 0.5 mg/mL aqueous solution thereof; the sulfated position is mainly at 6-hydroxy of the gastrodia elata polysaccharide, with mean molecular weight of 6.5×104 and a specific rotation of +150.0° in a 0.5 mg/mL aqueous solution thereof.

Abstract: The present invention discloses a sulfated derivative of polysaccharide extracted from gastrodia elata BL., the preparation method thereof and the use thereof in preparing antineoplastic medicaments, wherein, the gastrodia elata polysaccharide has the following structure: wherein, x and y are each an integer, and x+y=16, “n” is and integer, and the mean molecular weight of the polysaccharide from gastrodia elata is estimated as 2.8×105, the specific rotation of the polysaccharide is +95° in a 0.5 mg/mL aqueous solution thereof; the sulfated position is mainly at 6-hydroxy of the gastrodia elata polysaccharide, with mean molecular weight of 6.5×104 and a specific rotation of +150.0° in a 0.5 mg/mL aqueous solution thereof.